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Abstract
 .Calcium spirulan Ca-SP , a novel sulfated polysaccharide isolated from the blue-green alga Spirulina platensis, has been
found to have antiviral and heparin cofactor II-dependent antithrombin activities. We have obtained evidence that Ca-SP is a
 .potent inducer of tissue-type plasminogen activator t-PA production. The addition of Ca-SP to a culture of IMR-90 human
fetal lung fibroblasts increased t-PA concentrations in the conditioned medium, in a dose- and time-dependent manner, but
in the cell lysate, t-PA concentrations were unchanged, suggesting that t-PA induced by Ca-SP is easily secreted into the
w35 xconditioned medium. The amount of newly synthesized t-PA in IMR-90 cells, as measured by labeling with S methionine
and subsequent immunoprecipitation of t-PA from conditioned medium, was significantly increased by Ca-SP-stimulation.
However, Ca-SP did not increase the t-PA mRNA levels. As previously reported, thrombin stimulated t-PA gene
transcription in IMR-90 cells, and the simultaneous treatment with Ca-SP and thrombin caused further enhancement of t-PA
production, in a synergistic manner. It would thus appear that Ca-SP increases t-PA production through post-transcriptional
 .processes. IMR-90 cells also produce plasminogen activator inhibitor type-1 PAI-1 , but Ca-SP showed little effect on the
PAI-1 production. H-SP, which was obtained by removing the calcium from Ca-SP, had no effect on the t-PA production.
Na-SP, which was prepared by replacement of the calcium with sodium, stimulated the t-PA production similarly to Ca-SP.
Thus, Ca-SP specifically induces t-PA production, and the molecular conformation of Ca-SP maintained by Ca or Na may
be essential for the stimulation of t-PA synthesis.
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1. Introduction
  . xSpirulina Spirulina platensis Nordst. Geitl. is a
multicellular, filamentous cyanobacterium, belonging
to a blue-green alga of Cyanophyta. Because spir-
ulina contains much good-quality protein as well as
carotenoids, vitamins, and minerals, it has received
attention as a most promising and highly nutritious
food source. In addition, spirulina was recently proven
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in animal experiments to exhibit various biological
activities such as lowering plasma cholesterol levels
w x  .and blood pressure 1–3 . Calcium spirulan Ca-SP
is a novel acidic polysaccharide isolated from the hot
w xwater extract of spirulina by Hayashi et al. 4,5 .
They reported an inhibitory effect of Ca-SP on the
replication of enveloped viruses. We recently showed
that Ca-SP is a potent inhibitor of thrombin through
 .heparin cofactor II HC II , and that Ca-SP is a
sulfated polysaccharide distinct from heparin or der-
matan sulfate in an experiment of chondroitinase
w xtreatment 6 .
 .Plasminogen activators PA and their inhibitors
 .PAI regulate extracellular proteolysis and have been
implicated in a number of pathological processes.
Both u-PA and t-PA are serine proteases which cat-
alyze a conversion of the proenzyme plasminogen to
the active form plasmin and are believed to play
important roles in many aspects of cellular regulation,
such as fibrinolysis, tissue remodeling, inflammation
and tumor metastasis. Activation of plasminogen by
either t-PA or u-PA is inhibited by both PAI-1 and
PAI-2, which are members of the serpin superfamily
w xof protease inhibitors 7–12 . We have previously
shown that IMR-90 human fetal lung fibroblasts pro-
duce the four components of the plasminogen activat-
 .ing system t-PA, u-PA, PAI-1 and PAI-2 , and that
all of their gene transcriptions are up-regulated by
w xthrombin 13 .
Here we present evidence that Ca-SP stimulates
the synthesis of t-PA in IMR-90 cells by influencing
the post-transcriptional processes, and we show that
the removal of Ca from Ca-SP results in a significant
loss of the stimulating effect.
2. Materials and methods
2.1. Materials
The methods for isolation and purification of Ca-SP
w xwere described previously 5 . Removal of the cal-
cium from Ca-SP and replacement with sodium were
w xperformed as described previously 6 , and thus we
obtained H-SP and Na-SP, respectively. Human
thrombin was purchased from Sigma St. Louis, MO,
.USA . Polyclonal anti-human t-PA antibody was ob-
 .tained from TechnoClone GmbH Vienna, Austria .
Recombinant two chain t-PA native form, isolated
.from mammalian cells was a kind gift from Sumit-
 .omo Pharmaceutical Co. Osaka, Japan .
2.2. Cell culture
 .Human fetal lung fibroblasts IMR-90 were ob-
tained from Human Science Research Resources Bank
 .Osaka, Japan . The cells were grown in Eagle’s
minimal essential medium ICN Biomedicals Japan
.Co., Tokyo, Japan , supplemented with 10% fetal calf
 . serum, penicillin 100 IUrml and streptomycin 100
.mgrml under 5% CO , 95% air atmosphere at 378C.2
On Ca-SP stimulation, confluent monolayers of cells
 .were washed with phosphate buffered saline PBS
and resuspended in serum-free medium, ASF301
 .Ajinomoto Co., Tokyo, Japan containing various
concentrations of Ca-SP.
2.3. Antigen determinations
For the measurement of antigens, IMR-90 cells
were cultured in 24-well tissue culture plates Costar,
.Cambridge, MA, USA as previously described in
w x  .14 . Conditioned medium 0.25 ml was collected,
and the remaining cells were solubilized in 0.1 ml of
cell lysis buffer 0.5% Triton X-100 and 1 mM
.benzamidine-HCl in PBS after washing with PBS.
Antigen levels of t-PA in the conditioned medium
and cell lysate were then measured by a commer-
cially available ELISA kit, Imulysee tPA Biopool,
.Umea, Sweden . The concentration of PAI-1 in the
conditioned medium was measured by TintElizew
 .PAI-1 Biopool according to the manufacturer’s in-
structions. The results of antigen assays are expressed
as the mean"S.E. of four separate wells. Statistical
analysis was performed with the Student’s t-test to
compare unpaired data. P values less than 5% were
considered significant.
[ 35 ]2.4. Labeling of cell proteins with S methionine
and immunoprecipitation of t-PA
Labeling of proteins in IMR-90 cells and immuno-
precipitation were performed as follows. IMR-90 cells
cultured in 25-cm2 flasks were stimulated by 50
mgrml Ca-SP for 17 h. The medium was changed to
2 ml of L-methionine-free Eagle’s MEM containing 5
w35 x ml of L- S methionine 370 MBqrml, Amersham
.Corp., Buckinghamshire, UK , followed by culturing
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for 3 h. Conditioned medium was collected and then
incubated with pre-immune rabbit serum and subse-
 .quently with Protein A-Sepharose Sigma . After cen-
trifugation at 1000=g for 10 min, 0.5 ml of the
supernatant was further incubated with rabbit anti-hu-
man t-PA polyclonal antibody, and subsequently with
Protein A-sepharose. After centrifugation, the Protein
A-sepharose was washed with PET buffer PBS-
.EDTA-Tween 20 buffer and suspended in 20 ml of
Laemmli’s sample buffer for SDS-polyacrylamide gel
 .electrophoresis SDS-PAGE , boiled for 5 min, and
then centrifuged at 10 000=g for 10 min. The super-
 .natant 10 ml was subjected to SDS-PAGE using
7.5% polyacrylamide gel according to the method of
w xLaemmli, under non-reducing conditions 15 . The
proteins on the gel were fixed with 10% acetic acid
and 30% methanol, and then treated with
3  .EN HANCEe DuPont-NEN, Boston, MA, USA .
The dried gel was exposed to Kodak XAR film at
y708C with an intensifying screen.
2.5. Northern blot hybridization
RNA was isolated from cultured cells using the
acid-guanidium thiocyanate-phenol-chloroform
w xmethod 16 . 5 mg of total RNA were elec-
trophoresed, and hybridization was performed as de-
w xscribed elsewhere 13 . A 472-bp EcoRI t-PA cDNA
fragment was provided by Sumitomo Pharmaceutical
Co. b-actin cDNA probe was purchased from Wako
 .Pure Chemicals, Co. Osaka, Japan . These probes
w 32 x were labeled with a- P dCTP 111 TBqrmmol,
.ICN Biomedicals, Irvine, CA, USA using a random
primed DNA labeling kit Boehringer Mannheim
.GmbH, Mannheim, Germany according to the manu-
facturer’s instructions.
Each experiment was conducted a minimum of
three times; a representative set of data is provided in
the figures.
3. Results
3.1. Ca-SP stimulated t-PA production in IMR-90
cells
IMR-90 human fetal fibroblasts were cultured for
24 h with increasing amounts of Ca-SP, and then
Fig. 1. Dose-responsive stimulation of t-PA production in IMR-90
cells by Ca-SP. IMR-90 cells cultured in 24-well plates were
 .washed with PBS. ASF 301 medium serum-free medium con-
taining various concentrations of Ca-SP was added, and then the
cells were further cultured for 24 h. The concentration of t-PA in
the conditioned medium was measured by ELISA.
t-PA in the conditioned medium was quantitated by
ELISA. Ca-SP stimulated t-PA production in the
 .IMR-90 cells in a dose-dependent fashion Fig. 1 .
The stimulatory effect was seen with 10 mgrml
Ca-SP, and the stimulation to a 5.8-fold level oc-
curred with 50 mgrml Ca-SP. Heparin increased
t-PA antigen in the conditioned medium by only
1.6-fold, and dermatan sulfate had no stimulatory
effect at the concentration of 50 mgrml data not
.shown .
 .Ca-SP 50 mgrml rapidly increased the amount
of t-PA in the conditioned medium of IMR-90 cells,
and the increase was already observed at 0.5 h after
 .the addition of Ca-SP Fig. 2 . The stimulatory effect
of Ca-SP on t-PA production continued up to at least
24 h, and the t-PA concentration in the cultured
medium increased linearly. In contrast, the amount of
t-PA antigen in the cell lysate was not significantly
 .increased Fig. 3 . It was, therefore, suggested that
Ca-SP initially induced t-PA release and then stimu-
lated t-PA protein synthesis, and the newly synthe-
sized t-PA may have been immediately secreted from
the cells.
3.2. Ca-SP stimulated the rate of t-PA synthesis
To determine whether the increased concentration
of t-PA in the conditioned medium of IMR-90 cells
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Fig. 2. Time course of Ca-SP-induced accumulations of t-PA
antigens in the conditioned medium. IMR-90 cells were incu-
 .  .bated with v or without ‘ 50 mgrml Ca-SP for the times
indicated in the figure. The inset graph shows the time-course of
the change in the t-PA concentration during the initial 4 h after
the addition of Ca-SP.
with Ca-SP was due to the net synthesis of t-PA,
IMR-90 cells were preincubated in the absence or
presence of 50 mgrml Ca-SP for 17 h and then
w35 x 35labeled for 3 h with S methionine. S-labeled
t-PA in the medium was immunoprecipitated using
Fig. 3. Comparison of the concentration of t-PA in the condi-
tioned medium and the cell lysate in IMR-90 cells by Ca-SP
stimulation. IMR-90 cells were incubated in the presence or
absence of 50 mgrml Ca-SP during the various times indicated
in the figure. The conditioned medium was collected, and the cell
lysate was prepared as described in Section 2. The amount of
t-PA antigen was measured by ELISA. The data of this figure
express the mean value of four separate wells. Sup: the condi-
tioned medium, Cell: the cell lysate.
w35 xFig. 4. Increase in the amount of S methionine-labeled t-PA
immunoprecipitated from the conditioned medium of IMR-90
cells upon the addition of Ca-SP. IMR-90 cells were cultured for
 .  .17 h in the presence lane 3 or absence lane 4 of 50 mgrml
w35 xCa-SP. The cells were then pulse-labeled with S methionine
for 3 h in the medium depleted of methionine. Immunoprecipi-
tated proteins from the conditioned medium with anti-human
t-PA antiserum were analyzed by SDS-PAGE followed by auto-
 . radiography. Molecular marker lane 1 and two-chain t-PA lane
.2 in parallel electrophoresis were stained by Coomasie brilliant
blue.
polyclonal anti-t-PA antibody and then analyzed by
 .autoradiography after SDS-PAGE Fig. 4 . The auto-
radiography of 35S-labeled proteins showed that a
radiolabeled band with an apparent molecular mass
of 60 kDa was immunoprecipitated from the condi-
tioned medium of Ca-SP-treated cells. The 60 kDa
band corresponded to a two-chain t-PA band stained
by Coomasie brilliant blue in parallel electrophoresis.
In addition, the fibrinolytic activity at the position of
the 60 kDa band has been observed in our previous
w xreport 13 . In the absence of Ca-SP, the 60 kDa band
was not detectable. Therefore, the stimulatory effect
of Ca-SP on t-PA production was due to stimulation
of the net protein biosynthesis of t-PA.
3.3. Ca-SP did not alter the t-PA mRNA le˝el
We next examined changes in the t-PA mRNA
level when Ca-SP was added to cultures of IMR-90
cells. Seventeen hours after Ca-SP stimulation, RNA
was extracted and the t-PA mRNA level was deter-
 .mined by Northern hybridization Fig. 5 . Although
Ca-SP markedly stimulated t-PA production, there
was no significant increase in the t-PA mRNA level.
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Fig. 5. Northern blot analysis of t-PA mRNA in IMR-90 cells
treated with Ca-SP. IMR-90 cells were cultured in the presence
or absence of Ca-SP for 17 h and the RNA was extracted from
the cells. Northern blots were hybridized with 32P-labeled human
t-PA cDNA and rehybridized with b-actin cDNA probe. The
positions of 28 S and 18 S ribosomal RNA were checked at the
left side of autoradiography. Lane 1, untreated cells; lane 2, 12.5
mgrml Ca-SP-treated cells; lane 3, 50 mgrml Ca-SP-treated
cells.
The t-PA mRNA level in the cells of 6 hours after
Ca-SP addition was also not changed data not
.shown . Ca-SP, therefore, appears to have stimulated
t-PA synthesis through a translational mechanism,
and not by enhancing expression of the t-PA gene.
3.4. Synergistic effect of Ca-SP with thrombin
We have reported that thrombin is a potent stimu-
w xlator of t-PA production 14 and increases t-PA gene
Fig. 6. Effects of combination of thrombin with Ca-SP on t-PA
production in IMR-90 cells. The cells were cultured for 24 h in
ASF 301 medium containing 1 NIH Urml thrombin andror 50
mgrml Ca-SP. The concentration of t-PA in the conditioned
medium was measured by ELISA.
w xtranscription in IMR-90 cells 13 . Based on these
findings, we examined the combination effects of
Ca-SP and thrombin on t-PA production in IMR-90
 .cells Fig. 6 . Although Ca-SP alone stimulated t-PA
production by 3.1-fold, Ca-SP further enhanced t-PA
production induced by thrombin. The t-PA mRNA
level was markedly increased by the stimulation with
thrombin alone, but no further increase was observed
after the simultaneous stimulation with Ca-SP and
 .thrombin data not shown . The results also support
the notion that Ca-SP stimulates t-PA production
through a translational mechanism, whereas thrombin
regulates t-PA production through a transcriptional
mechanism.
3.5. Effect of Ca-SP on PAI-1 production
w xIn a previous report 13 , we showed that IMR-90
cells were constantly producing PAI-1 and the se-
creted PAI-1 seemed to form a complex with t-PA.
We therefore measured the antigen levels of PAI-1 in
the same samples shown in Fig. 1. PAI-1 antigen
levels were almost unchanged after Ca-SP stimula-
 .tion Fig. 7 .
3.6. Effects of H-SP and Na-SP on t-PA production
As shown in Fig. 8, H-SP had no stimulatory
effect on t-PA production in spite of the presence of
Fig. 7. Effects of Ca-SP on PAI-1 production in IMR-90 cells.
The PAI-1 antigen levels were measured in the same samples
described in Fig. 1, by ELISA. The results of antigen assays are
expressed as the mean value of four separate wells, in which the
induction fold of each antigen was compared with that in the
absence of Ca-SP.
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Fig. 8. Effects of H-SP and Na-SP on t-PA production in IMR-90
cells. Ca-SP, H-SP, or Na-SP was added to the cells at the
concentration of 50 mgrml. After the cells were cultured for 24
h, the amount of t-PA antigen in the conditioned medium was
))) .measured by ELISA P -0.001 .
sulfated groups. In contrast, Na-SP stimulated t-PA
production in IMR-90 cells similarly to Ca-SP. These
results indicate that the conformation of Ca-SP main-
tained by Ca or Na is important for the stimulation of
t-PA production.
4. Discussion
In previous studies, we showed that Ca-SP had
antiviral and HC II-dependent antithrombin activities
w x5,6 . In the present study, a novel biological function
of Ca-SP has been identified; that is, Ca-SP is a
potent enhancer of t-PA synthesis in IMR-90 cells.
By experiments using various cell lines, it has been
shown that the production of t-PA was regulated by
w xvarious agents, such as glucocorticoids 17 , cy-
w x w x w xtokines 18 , phorbol esters 19 , and thrombin 13,20 .
In these cases, the t-PA production was controlled at
the gene transcriptional level. We showed here that
Ca-SP stimulated t-PA production through the trans-
lational process. It is not known how Ca-SP transla-
tionally stimulates t-PA synthesis; the mechanism
should be elucidated in the future.
Among the sulfated polysaccharides, heparin has
been extensively studied for its biological functions
w xother than anticoagulant activity 21–26 . Recently,
Matsumoto et al. reported that heparin acts as a
potent inducer of hepatocyte growth factor produc-
w xtion by influencing post-transcriptional processes 27 .
Although Ca-SP is a novel sulfated polysaccharide
which is quite distinct from heparin, as shown in our
w xprevious report 6 , its various biological activities
will be discerned in the future, as has been the case
with heparin.
Although H-SP showed no significant induction of
t-PA production, the compound in which calcium was
 .replaced by sodium Na-SP retained the ability to
enhance t-PA synthesis. Therefore, the molecular
conformation maintained by calcium or sodium may
be important to the stimulation of t-PA synthesis by
Ca-SP. Our previous reports indicated the importance
of the metal ion of Ca-SP in the antiviral and anti-
w xthrombin effects 5,6 . The detailed structure of Ca-SP
is not yet clear and the relationship between structure
and function should be elucidated in further experi-
ments.
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